Nobody Wants Cancer. But a ‘Big C’ Label Has Surprising Upsides.

[Manouche]

« “The cancer designation did open up significant new funding opportunities, for example from the National Cancer Institute,” said Barbara Van Husen, board chair of the MPN Research Foundation. “It has definitely accelerated research.” There are more than 200 clinical trials underway for various MPNs, as well as ongoing research into stem cell transplantation, currently the only potential cure for these rare cancers »

nytimes.com/2021/03/11/well...

[hunter5582]

I don't worry about the "C" label at all. The disease is no different pre 2008 or post 2008. It is what it is. However, labels sometimes do matter when it comes to perceptions, priorities and funding. These diseases are in fact neoplasms and properly labeled as such now that the understanding is better. I am glad to hear that perhaps it has helped with the $$.